Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Stock Market News Updates

Monday, 27th December 2021

by Sumit Chanda
December 27, 2021
in Stock Market News Updates
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Over the weekend, major question marks were raised over the health of RBL Bank after the CEO was asked to proceed on leave and RBI nominated Yogesh Dayal to the board of RBL Bank. Sceptics have raised red flags about a Yes Bank like situation. It was also reported that Rakesh Jhunjhunwala and RK Damani had approached RBI to buy 10% in RBL Bank. Vishwavir Ahuja was temporarily replaced by Rajeev Ahuja. Its net NPAs stand at 2.14% but there have long been murmurs about the dubious asset quality of RBL Bank.

For the week ended 24-December, 5 out of the 10 most valuable companies on the Nifty added Rs.101,145 crore to their market cap. It was TCS and RIL that led the way. Among winners, TCS added Rs.30,721 crore, Reliance Industries Rs.21,036 crore, Infosys Rs.17,657 crore, Hindustan Unilever Rs.16,001 crore and Wipro Rs.15,731 crore. Among major losers, HDFC Bank lost Rs.18,620 crore HDFC Rs.15,084 crore and SBI Rs.9,728 crore. The Sensex was up during the week after the 3-day rally from Tuesday to Thursday. 

The Aluminium Association of India has asked for a hike in basic customs duty for aluminium and articles from 10% to 15%. This will correct the inverted duty structure. AAI has also demanded lower duties on critical raw materials like petcoke, caustic soda, aluminium fluoride and alumina in Budget-2023. In addition, the AAI has also demanded in the Budget, a hike in customs duty of primary aluminium from 7.5% to 10%, aluminium scrap from 2.5% to 10% and downstream aluminium products from 7.5% to 10%.

Karkinos Healthcare, the oncology-based managed healthcare platform, has received investment from Reliance Digital Health, a unit of Reliance Industries. Karkinos is backed by Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Vijay Shekhar Sharma and others. The Karkinos platform helps in the early detection and diagnosis of common cancers. Distributed cancer care has a huge potential in a country like India. Karkinos, meaning elimination of cancer, was floated by former Tata executives including Mr. Ravi Kant.

India imposed ant-dumping duties on 5 Chinese products, including aluminium goods and chemicals, for a period of 5 years to protect local manufacturers from cheap imports. According to CBIC, duties have been levied on flat rolled products of aluminium, sodium hydrosulphite, silicone sealant, HFC component R-32 etc. These were based on recommendations made by the Directorate General of Trade Remedies or DGTR. According to DGTR, these products were being dumped on India by China below the normal price.

In a landmark of sorts, global GDP is expected to cross $100 trillion in 2022. However, the report also forecast that China would now take 2 more years to overtake the US as the largest economy. According to the report, the biggest challenge for the global economies in 2022 will be tackling multi-year high levels of inflation. According to the report, Germany will overtake Japan in terms of GDP by 2033 while both Russia and Indonesia would figure among the top-10 companies by GDP by 2035. India will be at 6th place. 

Protean eGov Technologies, formerly NSDL E-Governance, filed DRHP with SEBI for its proposed Rs.1,300 crore IPO. The IPO will be an offer for sale. Major sellers in the OFS of Protean include IIFL Special Opportunities Funds, NSE, HDFC Bank, Axis Bank, Deutsche Bank, PNB and Union Bank. The issue will be lead managed by I-Sec, Equirus, IIFL Securities and Nomura Financial Advisory. Protean is involved in creating digital public infrastructure and developing innovative citizen-centric e-governance solutions. 

Even as Zee and Sony sign on the dotted line to merger their operations, there is an expensive exit clause. If either Zee or Sony decide to end the merger, the termination feel payable will be a whopping $100 million. Any break-up will be too expensive. This is subject to the shareholders and regulators giving the requisite approvals for the merger. Dissenting shareholder, Invesco, has not clarified whether it will vote for or against the merger. Improving corporate governance and operational performance will be the key.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Jarvis Invest

India's AI-powered, SEBI-registered investment advisory — research, portfolios and global market intelligence for every investor.

Company

  • About Us
  • FAQs
  • Contact Us
  • Become a Partner

Products

  • Jarvis Portfolio
  • Jarvis Protect
  • Jarvis OneStock
  • Jarvis Prime
  • Sentiment Tracker (F&O)
  • US Multi-Asset Portfolio

Explore Topics

  • Equity Markets
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Financial Planning
  • Portfolio Management
  • Stock Market News Updates
  • Global Stock Market

Get in touch

Customer support customersupport@jarvisinvest.com

Jarvis Invest — SEBI Registered Investment Adviser (Reg. No. INA000013235) & SEBI Registered Research Analyst (Reg. No. INH000018762). Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© 2026 Jarvis Invest. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Categories
Equity MarketsGet latest insights on the Indian equity market including stock trends, market analysis, sector…Investing BasicsLearn stock market basics including investing fundamentals, equity concepts, and beginner-friendly guides to start…AI for investingStay ahead with AI-powered stock insights, trend analysis, and intelligent investing strategies for ai…Trending Stock Market News: Quick ReadsDiscover the latest trends in the stock market with insightful blogs from Jarvis Invest…Portfolio ManagementExpert insights on portfolio management, asset allocation, risk management, and strategies to optimise best…Stock Market News UpdatesGet daily stock market news updates, key market movements, and insights that matter to…Global Stock MarketGet latest global stock market news, trends, and AI-driven stock insights on US, Europe…Stock AdvisoryLearn how AI-powered stock advisory and expert market research can help you build wealth.
I Am A
BeginnerBeginner-friendly stock market guides covering investing basics, common mistakes, and simple strategies to build…IntermediateIntermediate-level stock market insights covering investment strategies, portfolio analysis, and market concepts for informed…
Products
Jarvis PortfolioModel portfolio matched to your risk profile for long-term wealth creation.Jarvis ProtectContinuous portfolio monitoring for your existing portfolio with timely sell alerts to help manage downside risk.Jarvis OneStockHigh-conviction stock recommendations designed for short-term investing.Jarvis Prime - For HNIs & UHNIsPremium portfolio management services for investors with ₹25 lakh+ investment corpus.Jarvis Sentiment Tracker - AI Tool for F&OReal-time market sentiment analysis and trading signals for options traders.Jarvis US Multi-Asset PortfolioDiversified US portfolio investing across stocks and ETFs with automated portfolio management.Jarvis AtlasInvestment opportunities across Indian equities, global markets, and commodities in 10+ global markets.
No Result
View All Result
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version